deltatrials
Completed PHASE3 NCT00300157

Left Main Coronary Artery Stenosis and Angioplasty With Taxus Stent

French Multicenter Study Assessing Angioplasty With Taxus Drug Eluting Stent in Unprotected Left Main Coronary Artery Associated to Other Coronary Lesions or Not

Sponsor: Boston Scientific Corporation

Conditions Coronary Arteriosclerosis
Interventions Percutaneous coronary intervention with Taxus stent
Updated 6 times since 2017 Last updated: Jan 3, 2011 Started: Dec 31, 2005 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

A PHASE3 clinical study on Coronary Arteriosclerosis, this trial is completed. The trial is conducted by Boston Scientific Corporation and has accumulated 6 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Dec 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Boston Scientific Corporation
  • French Cardiology Society
Data source: French Cardiology Society

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aix-en-Provence, France, Avignon, France, Bordeaux, France, Brest, France, Caen, France, Lille, France, Lyon, France, Marseille, France, Massy, France, Metz, France and 10 more location s